Therefore, it can be concluded that the combination of Lobelia and fluoxetine significantly inhibited the neuroinflammatory response and ameliorated the resulting depression by inhibiting the COX-2/PGE2/IL-22 axis77. The gene discussed is PTGS2; the disease is depressive symptom measurement.